Prostamax. 20mg

$65.00

Prostamax 20 mg is a synthetic bioregulatory peptide studied for its potential role in supporting prostate and urogenital tissue function. It is primarily researched for its possible effects on cellular regulation, tissue regeneration, and prostate health mechanisms. Prostamax is commonly utilized in scientific investigations related to male reproductive health, hormonal balance pathways, and age-related prostate changes.

For Research Purposes Only.

Prostamax 20 mg is a synthetic bioregulatory peptide studied for its potential role in supporting prostate and urogenital tissue function. It is primarily researched for its possible effects on cellular regulation, tissue regeneration, and prostate health mechanisms. Prostamax is commonly utilized in scientific investigations related to male reproductive health, hormonal balance pathways, and age-related prostate changes.

For Research Purposes Only.

Prostamax (KEDP) research-use protocol

Disclaimer: This is an educational, research-only protocol based on publicly available information. It is not medical advice and not for human use.

Overview

• Name: Prostamax

• Sequence: Lys–Glu–Asp–Pro (KEDP)

• Class: Synthetic Khavinson tetrapeptide bioregulator, prostate-tissue–specific

• Proposed mechanism: Epigenetic modulation via chromatin structure changes (deheterochromatinization, altered DNA condensation, gene expression effects)

Reconstitution protocol (20 mg vial examples)

Option A – 2.0 mL dilution (10 mg/mL)

• Step 1: Add 2.0 mL bacteriostatic water to a 20 mg lyophilized vial.

• Step 2: Gently swirl until fully dissolved—avoid vigorous shaking.

• Step 3: Label vial with concentration (10 mg/mL) and date/time of reconstitution.

At 10 mg/mL:

• 1 unit on U100 insulin syringe (0.01 mL) ≈ 0.1 mg = 100 mcg

Option B – 3.0 mL dilution (~6.67 mg/mL)

• Step 1: Add 3.0 mL bacteriostatic water to a 20 mg vial.

• Step 2: Gently swirl to dissolve.

• Step 3: Label vial with concentration (~6.67 mg/mL) and date/time.

At ~6.67 mg/mL:

• 1 unit (0.01 mL) ≈ 66.7 mcg

Example experimental dosing ranges (research context only)

From peptide research references and dosage guides (not clinical dosing):

• Typical daily range (educational):

500–1000 mcg once daily

o Broader titration ranges up to 500–3000 mcg once daily are described in research-use protocols

• Route (preclinical models):

Subcutaneous (abdomen, thigh, upper arm) once daily

o Some protocols describe intramuscular once-daily approaches

• Cycle length:

10–20 days per experimental cycle is commonly referenced

Design of any invitro, exvivo, or invivo model should be aligned with institutional ethics, species-specific limits, and local regulations.

Storage and stability

• Lyophilized powder:

o Short-term: refrigerate at 4 °C

o Long-term: −20 °C, protected from light

• After reconstitution:

o Store at 2–8 °C (refrigerated)

o Use within typical lab stability windows; some guides suggest within ~2 weeks

• General handling:

o Avoid repeated freeze–thaw cycles.

o Keep protected from light to minimize degradation

Research applications (conceptual)

• Prostate tissue models: inflammation, remodeling, aging-related changes

• Epigenetic and chromatin studies: DNA condensation, heterochromatin/ euchromatin balance, NORs, sister chromatid exchanges

• Comparative bioregulator work: alongside other Khavinson peptides for tissue-specific effects

 

Available at TuraWellness.com